Asit C Mehta report on SBI Life Insurance Co
SBI Life Insurance reported premium income lower than our estimates by 6% mainly due to weakness in the group insurance and muted growth in the bancassurance cahannel. In terms of APE, growth was muted at 3% YoY, lower than our estimates by 4%. VNB declined by 3% YoY due to increased sale of ULIP products and high base of last FY while VNB margin reported a degrowth of 159bps. The company continues to launch new products to diversify its product offerings and is working on Agency 2.0 to strengthen its agency network. Although, the quarter remained muted in terms of APE/VNB growth, the company remains optimistic about the path going ahead and expects APE growth of 15-17% YoY.
Outlook
We expect its APE/NBP to grow at 17%/21% CAGR over FY24-27E. The company is currently trading at P/EV multiple of 2.3/2.0/1.7x of its FY25/26/27E embedded value. We maintain ‘Buy’ on SBI Life Insurance with a target price of Rs 2,015; valuing the company at 2.5x on its FY26E embedded value.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.